非洲富集GATM调控变异对肌酐估算eGFR的影响
研究利用乌干达5760人和南非827人的全基因组测序与表型数据,发现GATM位点非洲常见变异(等位基因频率约50%)与肌酐估算eGFR降低相关,而与实测GFR及胱抑素C估算eGFR无关。在非裔美国人中,这些变异与基于eGFRCr的CKD诊断 odds 增加相关,但与终末期肾病无关。
要点
- GATM非洲常见变异通过增强肌酸合成升高血肌酐,导致eGFRCr系统性偏低。
- 每携带一个等位基因,eGFRCr约低2 ml/min/1.73 m2,且独立于实测GFR。
- 该变异与实测GFR和胱抑素C估算eGFR无关,提示生物标志物特异性偏倚。
核心结论
- 非洲富集GATM变异与肌酐估算GFR的可测量偏倚相关,但无肾脏功能改变证据。
研究设计与样本
- 研究分析乌干达5760人和南非827人的全基因组测序与表型数据,整合GWAS、eQTL和代谢组学分析。
- 使用iohexol实测GFR量化肌酐估算eGFR的系统性偏倚,并在百万退伍军人计划非裔美国人参与者中评估诊断意义。
主要发现
- GATM位点变异在非洲人群常见(等位基因频率约50%),在欧洲人群中罕见或缺失。
- 这些变异解释eGFRCr变异的1.0%-1.7%,与GATM表达增加和肌酸合成增强相关,导致血肌酐升高和eGFRCr降低。
- 每个等位基因与eGFRCr约低2 ml/min/1.73 m2相关,且独立于实测GFR、年龄、性别和体成分。
- 这些变异与实测GFR或胱抑素C估算eGFR无关联,支持生物标志物特异性效应。
- 在非裔美国人中,GATM变异与基于eGFRCr阈值的CKD诊断 odds 增加相关,但与终末期肾病无关。
临床怎么用
- 在非洲裔人群中解读肌酐估算eGFR时,应考虑GATM变异带来的系统性偏低可能。
- 对疑似CKD诊断,可结合胱抑素C估算eGFR或实测GFR以降低误判风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Serum creatinine is a commonly used biomarker for estimating glomerular filtration rate (eGFR), but is influenced by determinants unrelated to kidney function, including muscle mass, age, sex, diet, and genetic variation. Biological drivers of persistent eGFR bias in African ancestry populations remain understudied. Here, we investigated whether African-enriched genetic variation at the glycine amidinotransferase (GATM) locus, encoding the rate limiting enzyme in creatine biosynthesis, contributes to systematic bias in creatinine-based estimates of GFR. METHODS: We analyzed whole-genome sequencing and phenotypic data from population-based cohorts in Uganda (5,760 individuals) and South Africa (827 individuals). Genome-wide association studies were integrated with expression quantitative trait locus and metabolomic analyses to characterize biological mechanisms. The iohexol measured GFR was used to quantify systematic bias for creatinine-based estimates (eGFRCr). Diagnostic implications were evaluated in African American participants of the Million Veteran Program. RESULTS: We described variants associated with eGFRCr at the GATM locus that were common in African populations (allele frequency about 50%) but rare or absent in Europeans. These variants explained 1.0%-1.7% of the variance in eGFRCr and were associated with increased GATM expression and enhanced creatine synthesis, resulting in higher serum creatinine and consequently lower eGFRCr. Each allele was associated with an approximately 2 ml/min per 1.73 m2 lower eGFRCr, and the association was independent of measured GFR, age, sex, and body composition. In contrast, these variants showed no association with measured GFR or cystatin C-based eGFR, supporting a biomarker-specific effect. In African American participants, GATM variants were associated with increased odds of a CKD diagnosis using eGFRCr thresholds but not with end-stage kidney disease. CONCLUSIONS: African-enriched GATM variants are associated with measurable bias in creatinine-based GFR estimation without evidence of altered kidney function. These findings improve understanding of differences in kidney function biomarkers and may be relevant when interpreting creatinine-based estimates, particularly in populations where the variant is common.
引用
- Gray OA, Yerges-Armstrong L, Castel SE, et al. Impact of African-enriched GATM regulatory variants on creatinine-derived estimated glomerular filtration rate. Kidney Int. 2026. PMID: 42498056. doi:10.1016/j.kint.2026.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。